Guangdong Vtr Bio-Tech Co., Ltd. (300381) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Guangdong Vtr Bio-Tech Co., Ltd.

Why is Guangdong Vtr Bio-Tech Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 1.41%

The company has been able to generate a Return on Capital Employed (avg) of 1.41% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -16.74% and Operating profit at -154.36% over the last 5 years

Flat results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY 38.12 MM
NET PROFIT(HY) At CNY 14.42 MM has Grown at -30.44%
DEBT-EQUITY RATIO (HY) Highest at -22.41 %

With ROE of 0.04%, it has a fair valuation with a 1.28 Price to Book Value

Over the past year, while the stock has generated a return of -15.97%, its profits have fallen by -94.9%
At the current price, the company has a high dividend yield of 1

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 16.01% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -15.97% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Guangdong Vtr Bio-Tech Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Guangdong Vtr Bio-Tech Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Guangdong Vtr Bio-Tech Co., Ltd.

-15.97%

0.10

33.60%

China Shanghai Composite

16.01%

1.07

14.97%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-16.74%

EBIT Growth (5y)

-154.36%

EBIT to Interest (avg)

-1.20

Debt to EBITDA (avg)

0.91

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

0.30

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

154.32%

Pledged Shares

Institutional Holding

ROCE (avg)

1.41%

ROE (avg)

2.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

3321

Industry P/E

Price to Book Value

1.28

EV to EBIT

-177.20

EV to EBITDA

24.98

EV to Capital Employed

1.37

EV to Sales

3.27

PEG Ratio

Dividend Yield

1.01%

ROCE (Latest)

-0.77%

ROE (Latest)

0.04%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 8.45 MM has Grown at 1,640.9%

NET PROFIT(Q)

At CNY 5.75 MM has Grown at 7,778%

RAW MATERIAL COST(Y)

Fallen by -24.77% (YoY

-13What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 38.12 MM

NET PROFIT(HY)

At CNY 14.42 MM has Grown at -30.44%

DEBT-EQUITY RATIO (HY)

Highest at -22.41 %

NET SALES(Q)

Lowest at CNY 198.11 MM

OPERATING PROFIT(Q)

Lowest at CNY 3.89 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 1.96 %

Here's what is working for Guangdong Vtr Bio-Tech Co., Ltd.

Pre-Tax Profit

At CNY 8.45 MM has Grown at 1,640.9%

over average net sales of the previous four periods of CNY -0.55 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 5.75 MM has Grown at 7,778%

over average net sales of the previous four periods of CNY -0.07 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Raw Material Cost

Fallen by -24.77% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guangdong Vtr Bio-Tech Co., Ltd.

Debt-Equity Ratio

Highest at -22.41 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow

Lowest at CNY 38.12 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 198.11 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 3.89 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 1.96 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales